Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

Overview of attention for article published in Molecular Cancer, July 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy: 1 policy source

patent: 2 patents

Citations

dimensions_citation: 274 Dimensions

Readers on

mendeley: 114 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer: Committee papers

Cited by National Institute for Health and Care Excellence on 02 Jun 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.